Last reviewed · How we verify
NCT03289247
Tissue Adhaesive in Wound Closure Following Primary Total Knee Arthroplasty
NA trial testing tissue adhesive (Leukosan®) in Total Knee Arthroplasty in 30 participants. Completed in 31 December 2018.
21 December 2017
Quick facts
| Lead sponsor | Hvidovre University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 September 2015 |
| Primary completion | 21 December 2017 |
| Estimated completion | 31 December 2018 |
Drugs / interventions tested
- tissue adhesive (Leukosan®)
Conditions studied
- Total Knee Arthroplasty — all drugs for Total Knee Arthroplasty →
- Infection — all drugs for Infection →
- Arthroplasty Complications — all drugs for Arthroplasty Complications →
Sponsor
Hvidovre University Hospital
Who can join
18 and older, any sex, with Total Knee Arthroplasty or Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study's primary objective is to compare the following parameters between wound closure following primary TKA with and without supplement tissue adhesive (Leukosan®):
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Tissue Adhesive for Wound Closure Reduces Immediate Postoperative Wound Dressing Changes After Primary TKA: A Randomized Controlled Study in Simultaneous Bilateral TKA.
Gromov K, Troelsen A, Raaschou S, Sandhold H, et al · · 2019 · cited 19× · PMID 30811354 · DOI 10.1097/corr.0000000000000637
Verify or expand the search:
- PubMed search for NCT03289247
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Total Knee Arthroplasty
Currently open trials in the same condition.
- NCT07524387 — Femoral Triangle Block vs Adductor Canal Block on Early Quadriceps Function After Total Knee Arthroplasty · NA · recruiting
- NCT07511842 — REST-Knee: A Pilot RCT of 72-Hour Knee Immobilization and Pain Outcomes · NA · recruiting
- NCT07324954 — Methylene Blue in Total Knee Arthroplasty (TKA) · Phase 1 · recruiting
- NCT07336160 — ERAS-Based Preoperative Nutrition and Fasting in Total Knee Arthroplasty · NA · recruiting
- NCT07371390 — Minimal Sedation During Knee Replacement Surgery · NA · recruiting
Other Hvidovre University Hospital trials
Trials by the same sponsor.
- NCT07561164 — Feasibility of a Co-designed Mobility Intervention After Hip Fracture Surgery · NA · not yet recruiting
- NCT06909240 — Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DV · NA · recruiting
- NCT07054216 — Probiotic for Infants · NA · recruiting
- NCT07029334 — Effectiveness Evaluation of Social Prescribing · recruiting
- NCT06789484 — Characterization of the Gastrointestinal Microbiota in Newborn Infants · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03289247 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hvidovre University Hospital
- Last refreshed: 25 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03289247.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing